BRIEF published on 11/25/2025 at 07:05, 9 months 16 days ago Le groupe Straumann annonce sa stratégie de croissance à moyen terme Stratégie De Croissance Objectifs Financiers Part De Marché Innovation Numérique Straumann AXS
BRIEF published on 11/25/2025 at 07:05, 9 months 16 days ago Relief Therapeutics and NeuroX Present Financial Outlook for Merger EBITDA Margin Financial Outlook Relief Therapeutics NeuroX Merger Digital Neurotherapeutics
BRIEF published on 11/25/2025 at 07:05, 9 months 16 days ago Relief Therapeutics et NeuroX présentent leurs perspectives financières en vue de leur fusion Marge D'EBITDA Perspectives Financières Thérapeutiques De Soulagement Fusion NeuroX Neurothérapie Numérique
BRIEF published on 11/25/2025 at 07:05, 9 months 16 days ago Dupixent : une avancée dans le traitement de l'urticaire chronique spontanée en Europe Sanofi Dupixent Regeneron Traitement Innovant Urticaire Chronique
BRIEF published on 11/25/2025 at 07:05, 9 months 16 days ago Dupixent: a breakthrough in the treatment of chronic spontaneous urticaria in Europe Innovative Treatment Sanofi Dupixent Regeneron Chronic Urticaria
BRIEF published on 11/25/2025 at 06:50, 9 months 16 days ago EPIC Suisse AG Publishes Q3 2025 Financial Overview Real Estate Income Q3 2025 Financial Results EPIC Suisse Portfolio Alrov Group Reporting PULSE Site Occupancy
BRIEF published on 11/25/2025 at 06:50, 9 months 16 days ago EPIC Suisse AG publie son aperçu financier du troisième trimestre 2025 Revenus Immobiliers Résultats Financiers Du Troisième Trimestre 2025 Portefeuille EPIC Suisse Rapports Du Groupe Alrov Occupation Du Site PULSE
BRIEF published on 11/25/2025 at 04:40, 9 months 16 days ago Forage d'amélioration de Tunkillia : Phase 1 achevée avec succès Production D'or Barton Gold Holdings Projet Aurifère De Tunkillia Phase 1 Forage Normes JORC
BRIEF published on 11/25/2025 at 04:40, 9 months 16 days ago Tunkillia Upgrade Drilling: Phase 1 Successfully Completed Gold Production Barton Gold Holdings Tunkillia Gold Project Phase 1 Drilling JORC Standards
BRIEF published on 11/25/2025 at 04:05, 9 months 16 days ago Visa Partners with M7 World Championship to Boost Digital Payments in Esports Esports Youth Empowerment Digital Payments MLBB Visa Partnership
Published on 09/11/2026 at 23:00, 1 hour 29 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 2 hours 24 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 3 hours 4 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 7 hours 29 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 7 hours 29 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 22:15, 2 hours 14 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 2 hours 19 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 4 hours 44 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 6 hours 14 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 17 hours 29 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 17 hours 29 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 17 hours 29 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 17 hours 29 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 4 hours ago Availability of the 2026 Interim Financial Report
